- Country: USA
- Summary: "Advancing Biodefense Readiness: On-Demand Biologics, Automated Threat Detection, and Alternative MCM Testing in High Containment”
- UST Ref No: 126086699
- Deadline: 10 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: MTEC-25-DTRA
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Medical Technology Enterprise Consortium (MTEC), in support of the Defense Threat Reduction Agency (DTRA), is excited to post this pre-announcement for an upcoming Request for Project Proposals (RPP) focused on advancing three medical and bioengineering technologies. The intent of the upcoming RPP is for interested Offerors to respond to only one of the following Focus Areas; however, it is permissible for an Offeror to submit a separate white paper in response to one or more of the focus areas:FOCUS AREA #1: Biologics On Demand: This focus area (which is further detailed below) aims to advance the state-of-the-art for producing biologics on-demand and near point-of-need with the following characteristics:
• Achieving relevant quantities of medical countermeasures (MCM).• Ensuring initiation of protein production within
24 hours of receiving DNA/RNA template.• Producing fully bioactive complex proteins.• Demonstration of identical runs at different locations.• Feasibility to advance products to and through regulatory approval.
FOCUS AREA #2: Automated Clinical and/or Environmental Sampling, Sequencing, and Analysis: This focus area (which is further detailed below) aims to advance the development of an integrated, automated system capable of detecting and identifying biological threats in environmental samples with the following characteristics:• Automated collection of representative samples from various sources (air, water, wastewater, NP swabs, serum, plasma, urine, etc.).• Onboard liquid handling for nucleic acid extraction and library preparation.• Integration with a platform that can provide real-time sequencing and identification of biological agents in environmental matrices.• Embedded bioinformatics tools for immediate analysis and reporting of sequencing data.
FOCUS AREA #3: Alternative Methods for Testing MCMs in High Containment: This focus area (which is further detailed below) aims to advance alternative models, suc... - Documents:
MTEC-25-DTRA-preannouncement_v4-FINAL.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN"Advancing Biodefense Readiness: On-Demand Biologics, Automated Threat Detection, and Alternative MCM Testing in High Containment” - USA Tender
The DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA), a Government sector organization in USA, has announced a new tender for "Advancing Biodefense Readiness: On-Demand Biologics, Automated Threat Detection, and Alternative MCM Testing in High Containment”. This tender is published on USARFP under UST Ref No: 126086699 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
